Results 171 to 180 of about 1,327,526 (267)

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Spatial distribution and risk assessment of dengue incidence at district level across major climatic zones in India. [PDF]

PLoS One
James MM, Balasubramani K, Balabaskaran Nina P, Gopalan N, Behera SK.   +4 more
europepmc   +1 more source

President's Annual Report [PDF]

American Association of Industrial Nurses Journal, 1966
openaire   +4 more sources

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Popular Financial Report of Harvard University FY 2024

European Journal of Volunteering and Community-Based Projects
Riccardo Corsi, Luca Accossato, Davide Ciniero, Federico Gribaldo   +3 more
doaj   +2 more sources

Cell Therapy '98: An Introduction

Cell Transplantation, 1999
Morito Monden
doaj   +1 more source

Masting Breakdown in European Beech Reduces Fitness Benefits of Masting, Partly Explained by Climate Change. [PDF]

Ecol Evol
Jantzen CC, Burant JB, Gamelon M, Bakker ES, Visser ME.   +4 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Cell Therapy ‘99: Introduction

Cell Transplantation, 2000
Hiroshi Amemiya
doaj   +1 more source